Evidence map›Paper›PMID 35360870›Full record

ArticleFrontiers in genetics2022

Identification of Pathologic and Prognostic Genes in Prostate Cancer Based on Database Mining.

Kun Liu, Yijun Chen, Pengmian Feng, Yucheng Wang, Mengdi Sun, Tao Song, Jun Tan, Chunyang Li, Songpo Liu, Qinghong Kong and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in genetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
0.8field-weighted citation impact, top 34% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 8 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Comparative efficacy of radical prostatectomy and radiotherapy in the treatment of high-risk prostate cancer.Technology and health care : official journal of the European Society for Engineering and Medicine · 2024
    Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 2 institutions in 1 country.

Kun LiuDepartment of Immunology, Zunyi Medical University, Zunyi, China.
Yijun ChenDepartment of Immunology, Zunyi Medical University, Zunyi, China.
Pengmian FengSchool of Basic Medical Sciences, Chengdu University of Traditional Chinese Medicine, Chengdu, China.
Yucheng WangDepartment of Immunology, Zunyi Medical University, Zunyi, China.
Mengdi SunDepartment of Immunology, Zunyi Medical University, Zunyi, China.
Tao SongDepartment of Immunology, Zunyi Medical University, Zunyi, China.
Jun TanDepartment of Histology and Embryology, Zunyi Medical University, Zunyi, China.
Chunyang LiDepartment of Immunology, Zunyi Medical University, Zunyi, China.
Songpo LiuDepartment of Immunology, Zunyi Medical University, Zunyi, China.
Qinghong KongGuizhou Provincial College-based Key Lab for Tumor Prevention and Treatment with Distinctive Medicines, Zunyi Medical University, Zunyi, China.
Jidong ZhangDepartment of Immunology, Zunyi Medical University, Zunyi, China.
Zunyi Medical University · CNChengdu University of Traditional Chinese Medicine · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

biomarkerdifferentially expressed genesprognosisprostate cancerTCGA

Identifiers

PMID35360870
PMCPMC8963346
OpenAlexW4220897911

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.